nodes	percent_of_prediction	percent_of_DWPC	metapath
Pefloxacin—TOP2A—prostate cancer	0.448	1	CbGaD
Pefloxacin—TOP2A—Mitoxantrone—prostate cancer	0.124	0.257	CbGbCtD
Pefloxacin—TOP2A—Epirubicin—prostate cancer	0.1	0.208	CbGbCtD
Pefloxacin—TOP2A—Etoposide—prostate cancer	0.0782	0.162	CbGbCtD
Pefloxacin—TOP2A—Doxorubicin—prostate cancer	0.0533	0.11	CbGbCtD
Pefloxacin—CYP1A2—Flutamide—prostate cancer	0.0441	0.0913	CbGbCtD
Pefloxacin—CYP1A2—Estrone—prostate cancer	0.0319	0.066	CbGbCtD
Pefloxacin—CYP1A2—Conjugated Estrogens—prostate cancer	0.0209	0.0432	CbGbCtD
Pefloxacin—CYP1A2—Estradiol—prostate cancer	0.0183	0.0379	CbGbCtD
Pefloxacin—CYP1A2—Etoposide—prostate cancer	0.012	0.0248	CbGbCtD
Pefloxacin—TOP2A—Docetaxel—Cabazitaxel—prostate cancer	0.00109	0.267	CbGdCrCtD
Pefloxacin—TOP2A—Paclitaxel—Cabazitaxel—prostate cancer	0.000754	0.184	CbGdCrCtD
Pefloxacin—Enoxacin—TOP2A—prostate cancer	0.00057	0.156	CrCbGaD
Pefloxacin—Lomefloxacin—TOP2A—prostate cancer	0.000432	0.118	CrCbGaD
Pefloxacin—Ofloxacin—TOP2A—prostate cancer	0.000369	0.101	CrCbGaD
Pefloxacin—Levofloxacin—TOP2A—prostate cancer	0.000369	0.101	CrCbGaD
Pefloxacin—Ciprofloxacin—TOP2A—prostate cancer	0.000356	0.0976	CrCbGaD
Pefloxacin—TOP2A—Paclitaxel—Docetaxel—prostate cancer	0.000313	0.0765	CbGdCrCtD
Pefloxacin—Norfloxacin—TOP2A—prostate cancer	0.000299	0.082	CrCbGaD
Pefloxacin—Ciprofloxacin—CYP3A5—prostate cancer	0.000281	0.077	CrCbGaD
Pefloxacin—Norfloxacin—CYP3A5—prostate cancer	0.000236	0.0647	CrCbGaD
Pefloxacin—Norfloxacin—CYP2A6—prostate cancer	0.000229	0.0626	CrCbGaD
Pefloxacin—TOP2A—Fulvestrant—Estradiol—prostate cancer	0.000229	0.0558	CbGdCrCtD
Pefloxacin—TOP2A—Teniposide—Etoposide—prostate cancer	0.000201	0.0491	CbGdCrCtD
Pefloxacin—TOP2A—Podofilox—Etoposide—prostate cancer	0.000201	0.0491	CbGdCrCtD
Pefloxacin—TOP2A—Levorphanol—Estrone—prostate cancer	0.000199	0.0487	CbGdCrCtD
Pefloxacin—Norfloxacin—CYP1A1—prostate cancer	0.00016	0.0439	CrCbGaD
Pefloxacin—TOP2A—Levorphanol—Estradiol—prostate cancer	0.000151	0.0369	CbGdCrCtD
Pefloxacin—TOP2A—Methyltestosterone—Ethinyl Estradiol—prostate cancer	0.000138	0.0337	CbGdCrCtD
Pefloxacin—Levofloxacin—CYP3A4—prostate cancer	0.000126	0.0345	CrCbGaD
Pefloxacin—Ciprofloxacin—CYP3A4—prostate cancer	0.000122	0.0333	CrCbGaD
Pefloxacin—TOP2A—Idarubicin—Epirubicin—prostate cancer	0.000105	0.0256	CbGdCrCtD
Pefloxacin—TOP2A—Doxorubicin—Epirubicin—prostate cancer	0.000105	0.0256	CbGdCrCtD
Pefloxacin—TOP2A—Daunorubicin—Epirubicin—prostate cancer	0.000105	0.0256	CbGdCrCtD
Pefloxacin—Norfloxacin—CYP3A4—prostate cancer	0.000102	0.028	CrCbGaD
Pefloxacin—TOP2A—Epirubicin—Doxorubicin—prostate cancer	9.71e-05	0.0237	CbGdCrCtD
Pefloxacin—TOP2A—Idarubicin—Doxorubicin—prostate cancer	9.71e-05	0.0237	CbGdCrCtD
Pefloxacin—TOP2A—Daunorubicin—Doxorubicin—prostate cancer	9.71e-05	0.0237	CbGdCrCtD
Pefloxacin—TOP2A—Norethindrone—Ethinyl Estradiol—prostate cancer	8.99e-05	0.0219	CbGdCrCtD
Pefloxacin—TOP2A—Levonorgestrel—Ethinyl Estradiol—prostate cancer	7.15e-05	0.0175	CbGdCrCtD
Pefloxacin—CYP1A2—Metapathway biotransformation—GSTO1—prostate cancer	5.94e-05	0.000964	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—NAT2—prostate cancer	5.94e-05	0.000964	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CCND2—prostate cancer	5.93e-05	0.000961	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—prostate cancer	5.87e-05	0.000952	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—CYP2C18—prostate cancer	5.78e-05	0.000937	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—CYP2C18—prostate cancer	5.7e-05	0.000924	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CHEK2—prostate cancer	5.66e-05	0.000917	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MAP2K1—prostate cancer	5.62e-05	0.000911	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—prostate cancer	5.62e-05	0.000911	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—COMT—prostate cancer	5.56e-05	0.000902	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	5.56e-05	0.000902	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—GSTP1—prostate cancer	5.54e-05	0.000898	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—APEX1—prostate cancer	5.5e-05	0.000891	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	5.45e-05	0.000884	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—SULT2A1—prostate cancer	5.37e-05	0.000871	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—prostate cancer	5.31e-05	0.000862	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	5.31e-05	0.00086	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—BRCA1—prostate cancer	5.3e-05	0.00086	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CCND2—prostate cancer	5.3e-05	0.00086	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—SULT2A1—prostate cancer	5.3e-05	0.000859	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	5.25e-05	0.000852	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	5.13e-05	0.000832	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	5.12e-05	0.00083	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—TYMS—prostate cancer	5.1e-05	0.000827	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CBR1—prostate cancer	5.1e-05	0.000827	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GRHL1—prostate cancer	5.1e-05	0.000827	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—GSTM1—prostate cancer	5.09e-05	0.000825	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—GPX3—prostate cancer	5.05e-05	0.00082	CbGpPWpGaD
Pefloxacin—CYP1A2—Tryptophan metabolism—MDM2—prostate cancer	5e-05	0.000811	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—PTEN—prostate cancer	4.92e-05	0.000797	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	4.88e-05	0.000792	CbGpPWpGaD
Pefloxacin—TOP2A—Methyltestosterone—Prednisone—prostate cancer	4.84e-05	0.0118	CbGdCrCtD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—prostate cancer	4.82e-05	0.000782	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—HPGDS—prostate cancer	4.82e-05	0.000781	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—BRCA2—prostate cancer	4.79e-05	0.000777	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—CYP2C19—prostate cancer	4.79e-05	0.000776	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	4.75e-05	0.00077	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—CYP2C19—prostate cancer	4.72e-05	0.000766	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—EP300—prostate cancer	4.69e-05	0.00076	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—GSTT1—prostate cancer	4.67e-05	0.000758	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	4.62e-05	0.00075	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—CYP2A6—prostate cancer	4.62e-05	0.000749	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—prostate cancer	4.57e-05	0.00074	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—prostate cancer	4.57e-05	0.00074	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—TYMS—prostate cancer	4.56e-05	0.00074	CbGpPWpGaD
Pefloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—prostate cancer	4.51e-05	0.000731	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—prostate cancer	4.47e-05	0.000724	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—MBTPS1—prostate cancer	4.46e-05	0.000723	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—AKR1C3—prostate cancer	4.43e-05	0.000719	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—CYP17A1—prostate cancer	4.42e-05	0.000717	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—CYP17A1—prostate cancer	4.36e-05	0.000708	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	4.26e-05	0.00069	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	4.24e-05	0.000688	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AMACR—prostate cancer	4.22e-05	0.000685	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—prostate cancer	4.22e-05	0.000685	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—DEGS1—prostate cancer	4.22e-05	0.000685	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—NCOA2—prostate cancer	4.22e-05	0.000684	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—prostate cancer	4.21e-05	0.000683	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	4.16e-05	0.000675	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B1—prostate cancer	4.03e-05	0.000653	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—prostate cancer	4.01e-05	0.00065	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—prostate cancer	4.01e-05	0.00065	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—TERT—prostate cancer	3.97e-05	0.000644	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	3.93e-05	0.000638	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—CYP2E1—prostate cancer	3.93e-05	0.000637	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—prostate cancer	3.9e-05	0.000632	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—prostate cancer	3.9e-05	0.000632	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—CYP2E1—prostate cancer	3.87e-05	0.000628	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—prostate cancer	3.8e-05	0.000616	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—CYP3A4—prostate cancer	3.79e-05	0.000614	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—CYP3A4—prostate cancer	3.74e-05	0.000606	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—CYP1B1—prostate cancer	3.72e-05	0.000604	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—CYP1B1—prostate cancer	3.67e-05	0.000596	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	3.61e-05	0.000586	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—GGT1—prostate cancer	3.61e-05	0.000585	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—prostate cancer	3.59e-05	0.000582	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—ATM—prostate cancer	3.57e-05	0.000579	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—NCOA1—prostate cancer	3.55e-05	0.000576	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—CYP19A1—prostate cancer	3.5e-05	0.000568	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	3.49e-05	0.000567	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—prostate cancer	3.49e-05	0.000566	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—prostate cancer	3.49e-05	0.000565	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—CYP19A1—prostate cancer	3.45e-05	0.00056	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—prostate cancer	3.42e-05	0.000554	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—prostate cancer	3.42e-05	0.000554	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—RXRA—prostate cancer	3.38e-05	0.000548	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—TNFRSF21—prostate cancer	3.38e-05	0.000548	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—TP53—prostate cancer	3.35e-05	0.000544	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP7B1—prostate cancer	3.29e-05	0.000533	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—COMT—prostate cancer	3.26e-05	0.000528	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—GSTP1—prostate cancer	3.24e-05	0.000525	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—prostate cancer	3.23e-05	0.000523	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—COMT—prostate cancer	3.21e-05	0.000521	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—prostate cancer	3.2e-05	0.000519	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—GSTP1—prostate cancer	3.2e-05	0.000518	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—IL6—prostate cancer	3.07e-05	0.000498	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ACSL4—prostate cancer	3.05e-05	0.000495	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B3—prostate cancer	3.05e-05	0.000495	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—GSTM1—prostate cancer	2.98e-05	0.000483	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	2.95e-05	0.000479	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—GSTM1—prostate cancer	2.94e-05	0.000476	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—CYP1A1—prostate cancer	2.82e-05	0.000458	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—HAO1—prostate cancer	2.79e-05	0.000452	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—CYP1A1—prostate cancer	2.78e-05	0.000451	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—prostate cancer	2.69e-05	0.000437	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—MDM2—prostate cancer	2.64e-05	0.000427	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	2.6e-05	0.000421	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—prostate cancer	2.57e-05	0.000416	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	2.49e-05	0.000404	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—prostate cancer	2.48e-05	0.000403	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CDKN1B—prostate cancer	2.41e-05	0.00039	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	2.4e-05	0.000389	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—EP300—prostate cancer	2.36e-05	0.000383	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	2.31e-05	0.000375	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CCND1—prostate cancer	2.3e-05	0.000372	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ADI1—prostate cancer	2.27e-05	0.000368	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PSAT1—prostate cancer	2.27e-05	0.000368	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CSAD—prostate cancer	2.27e-05	0.000368	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—TST—prostate cancer	2.27e-05	0.000368	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CBR1—prostate cancer	2.27e-05	0.000368	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GRHL1—prostate cancer	2.27e-05	0.000368	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CDKN1A—prostate cancer	2.22e-05	0.00036	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	2.22e-05	0.00036	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	2.18e-05	0.000353	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—EP300—prostate cancer	2.11e-05	0.000343	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CKMT2—prostate cancer	2.11e-05	0.000342	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—UGT2B15—prostate cancer	2.11e-05	0.000342	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GRHPR—prostate cancer	2.11e-05	0.000342	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—UGT2B17—prostate cancer	2.11e-05	0.000342	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	2.06e-05	0.000335	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—MYC—prostate cancer	2.06e-05	0.000334	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—MED12—prostate cancer	2.03e-05	0.000329	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SULT2B1—prostate cancer	1.98e-05	0.000322	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—MBTPS1—prostate cancer	1.98e-05	0.000322	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—AOX1—prostate cancer	1.98e-05	0.000322	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PGAM2—prostate cancer	1.98e-05	0.000322	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTM3—prostate cancer	1.98e-05	0.000322	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NAGLU—prostate cancer	1.98e-05	0.000322	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—RFK—prostate cancer	1.98e-05	0.000322	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	1.94e-05	0.000315	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP3A43—prostate cancer	1.88e-05	0.000305	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—AMACR—prostate cancer	1.88e-05	0.000305	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SRD5A2—prostate cancer	1.88e-05	0.000305	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NAT1—prostate cancer	1.88e-05	0.000305	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—DEGS1—prostate cancer	1.88e-05	0.000305	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	1.85e-05	0.0003	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—MYC—prostate cancer	1.84e-05	0.000299	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	1.84e-05	0.000298	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—HSD17B1—prostate cancer	1.79e-05	0.000291	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	1.79e-05	0.000291	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	1.73e-05	0.00028	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	1.72e-05	0.000278	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	1.7e-05	0.000275	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	1.62e-05	0.000263	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—B4GALT4—prostate cancer	1.6e-05	0.000259	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—HPGD—prostate cancer	1.6e-05	0.000259	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—TP53—prostate cancer	1.51e-05	0.000245	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—TNFRSF21—prostate cancer	1.5e-05	0.000244	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP7B1—prostate cancer	1.46e-05	0.000237	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—MTAP—prostate cancer	1.46e-05	0.000237	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	1.43e-05	0.000232	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SULT1E1—prostate cancer	1.43e-05	0.000231	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SRD5A1—prostate cancer	1.43e-05	0.000231	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	1.38e-05	0.000225	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	1.36e-05	0.000221	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ACSL4—prostate cancer	1.36e-05	0.000221	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—HSD17B3—prostate cancer	1.36e-05	0.000221	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	1.34e-05	0.000218	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—UMPS—prostate cancer	1.3e-05	0.000211	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PHGDH—prostate cancer	1.3e-05	0.000211	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ARG2—prostate cancer	1.3e-05	0.000211	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	1.3e-05	0.00021	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—LDHB—prostate cancer	1.28e-05	0.000207	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP3A5—prostate cancer	1.26e-05	0.000204	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PDHA1—prostate cancer	1.21e-05	0.000197	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—UCP3—prostate cancer	1.21e-05	0.000197	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTA3—prostate cancer	1.21e-05	0.000197	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—TCN2—prostate cancer	1.21e-05	0.000197	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—HSD3B1—prostate cancer	1.16e-05	0.000188	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SLC22A3—prostate cancer	1.16e-05	0.000188	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LPL—prostate cancer	1.12e-05	0.000182	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTA4—prostate cancer	1.11e-05	0.00018	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—TBXAS1—prostate cancer	1.11e-05	0.00018	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	1.08e-05	0.000176	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTA2—prostate cancer	1.08e-05	0.000175	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SULT1A1—prostate cancer	1.07e-05	0.000173	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ABCG5—prostate cancer	1.07e-05	0.000173	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTA1—prostate cancer	1.04e-05	0.000169	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTO1—prostate cancer	1.03e-05	0.000167	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—HSD3B2—prostate cancer	1.03e-05	0.000167	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NAT2—prostate cancer	1.03e-05	0.000167	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	9.91e-06	0.000161	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PLCB2—prostate cancer	9.88e-06	0.00016	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—LRP2—prostate cancer	9.88e-06	0.00016	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP2C18—prostate cancer	9.88e-06	0.00016	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—P4HB—prostate cancer	9.69e-06	0.000157	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SLC22A1—prostate cancer	9.43e-06	0.000153	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	9.32e-06	0.000151	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SULT2A1—prostate cancer	9.19e-06	0.000149	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—MED12—prostate cancer	9.04e-06	0.000147	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GNG5—prostate cancer	8.97e-06	0.000145	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NCOA3—prostate cancer	8.64e-06	0.00014	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	8.49e-06	0.000138	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—HPGDS—prostate cancer	8.24e-06	0.000134	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP2C19—prostate cancer	8.19e-06	0.000133	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTT1—prostate cancer	7.99e-06	0.00013	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ACHE—prostate cancer	7.99e-06	0.00013	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP2A6—prostate cancer	7.9e-06	0.000128	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	7.87e-06	0.000128	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—AKR1C3—prostate cancer	7.69e-06	0.000125	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PRKACB—prostate cancer	7.65e-06	0.000124	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP17A1—prostate cancer	7.57e-06	0.000123	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	7.46e-06	0.000121	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NCOA2—prostate cancer	7.21e-06	0.000117	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SLC5A5—prostate cancer	6.88e-06	0.000112	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP2E1—prostate cancer	6.72e-06	0.000109	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NQO1—prostate cancer	6.64e-06	0.000108	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—TH—prostate cancer	6.55e-06	0.000106	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	6.5e-06	0.000105	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP3A4—prostate cancer	6.48e-06	0.000105	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	6.44e-06	0.000105	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP1B1—prostate cancer	6.37e-06	0.000103	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GGT1—prostate cancer	6.17e-06	0.0001	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NCOA1—prostate cancer	6.08e-06	9.85e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP19A1—prostate cancer	5.99e-06	9.71e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—RXRA—prostate cancer	5.78e-06	9.37e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	5.62e-06	9.11e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—COMT—prostate cancer	5.57e-06	9.03e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTP1—prostate cancer	5.54e-06	8.98e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ITPR1—prostate cancer	5.45e-06	8.84e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	5.36e-06	8.69e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—TYMS—prostate cancer	5.15e-06	8.35e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTM1—prostate cancer	5.09e-06	8.26e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—LPL—prostate cancer	5e-06	8.1e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP1A1—prostate cancer	4.83e-06	7.83e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ERCC2—prostate cancer	4.79e-06	7.76e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—MTHFR—prostate cancer	4.5e-06	7.3e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PPARA—prostate cancer	4.41e-06	7.16e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CAV1—prostate cancer	4.15e-06	6.73e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.97e-06	6.43e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PIK3CG—prostate cancer	3.78e-06	6.13e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—INS—prostate cancer	3.58e-06	5.8e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CREBBP—prostate cancer	3.51e-06	5.68e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PIK3CD—prostate cancer	3.32e-06	5.39e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NOS3—prostate cancer	3.14e-06	5.09e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PIK3CB—prostate cancer	2.9e-06	4.7e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PTGS2—prostate cancer	2.87e-06	4.65e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PTEN—prostate cancer	2.5e-06	4.06e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—EP300—prostate cancer	2.39e-06	3.87e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PIK3CA—prostate cancer	1.77e-06	2.86e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—AKT1—prostate cancer	1.44e-06	2.34e-05	CbGpPWpGaD
